A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status
| Image |  |
|---|---|
| Description | scientific article published on 18 July 2017 |
| Author/s |
author: Benjamin Izar F Stephen Hodi Reinhard Dummer Keith Flaherty |
| Publication date | July 18, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |